243 related articles for article (PubMed ID: 29704269)
21. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
[TBL] [Abstract][Full Text] [Related]
22. CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis.
Takeuchi M; Kobayashi T; Biss T; Kamali F; Vear SI; Ho RH; Bajolle F; Loriot MA; Shaw K; Carleton BC; Hamberg AK; Wadelius M; Hirono K; Taguchi M; Wakamiya T; Yanagimachi M; Hirai K; Itoh K; Brandão LR; Ito S
Pharmacogenomics J; 2020 Apr; 20(2):306-319. PubMed ID: 31673144
[TBL] [Abstract][Full Text] [Related]
23. Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves.
An SH; Lee KE; Chang BC; Gwak HS
J Clin Pharm Ther; 2014 Jun; 39(3):314-8. PubMed ID: 24602049
[TBL] [Abstract][Full Text] [Related]
24. Effect of gene polymorphims on the warfarin treatment at initial stage.
Liu J; Jiang HH; Wu DK; Zhou YX; Ye HM; Li X; Luo ZY; Guo Z; Zhang YL; Wang YC; Zhang W; Zhou HH; Wang LS
Pharmacogenomics J; 2017 Jan; 17(1):47-52. PubMed ID: 26644206
[TBL] [Abstract][Full Text] [Related]
25. Chinese Patients With Heart Valve Replacement Do Not Benefit From Warfarin Pharmacogenetic Testing on Anticoagulation Outcomes.
Hao Y; Yang J; Zheng X; Hu Y; Yan X; Zhang L
Ther Drug Monit; 2019 Dec; 41(6):748-754. PubMed ID: 31259883
[TBL] [Abstract][Full Text] [Related]
26. Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial.
Guo C; Kuang Y; Zhou H; Yuan H; Pei Q; Li J; Jiang W; Ng CM; Chen X; Huo Y; Cui Y; Wang X; Yu J; Sun X; Yu W; Chen P; Miao D; Liu W; Yu Z; Ouyang Z; Shi X; Lv C; Peng Z; Xiong G; Zeng G; Zeng J; Dai H; Peng J; Zhang Y; Xu F; Wu J; Chen X; Gong H; Yang Z; Wu X; Fang Q; Yang L; Li H; Tan H; Huang Z; Tang X; Yang Q; Tu S; Wang X; Xiang Y; Huang J; Wang X; Cai J; Jiang S; Huang L; Peng J; Gong L; Zou C; Yang G
Circ Genom Precis Med; 2020 Aug; 13(4):e002602. PubMed ID: 32510984
[TBL] [Abstract][Full Text] [Related]
27. CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients.
Panchenko E; Kropacheva E; Dobrovolsky A; Titaeva E; Zemlyanskaya O; Trofimov D; Galkina I; Lifshits G; Vereina N; Sinitsin S; Vorobyeva N; Grehova L; Zateyshchikov D; Zotova I; Vavilova T; Sirotkina O; Grontkovskaya A
Pharmacogenomics J; 2020 Oct; 20(5):687-694. PubMed ID: 32024944
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support.
Awad M; Czer LS; Soliman C; Mirocha J; Ruzza A; Pinzas J; Rihbany K; Chang D; Moriguchi J; Ramzy D; Esmailian F; Kobashigawa J; Arabia F
ASAIO J; 2015; 61(4):391-6. PubMed ID: 26125664
[TBL] [Abstract][Full Text] [Related]
29. Meta-Analysis of Genotype-Guided Versus Standard Dosing of Vitamin K Antagonists.
Kheiri B; Abdalla A; Haykal T; Osman M; Ahmed S; Hassan M; Bachuwa G
Am J Cardiol; 2018 Apr; 121(7):879-887. PubMed ID: 29402419
[TBL] [Abstract][Full Text] [Related]
30. Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.
You JH; Tsui KK; Wong RS; Cheng G
Clin Pharmacol Ther; 2009 Nov; 86(5):540-7. PubMed ID: 19571807
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in VKORC1 have more impact than CYP2C9 polymorphisms on early warfarin International Normalized Ratio control and bleeding rates.
Lund K; Gaffney D; Spooner R; Etherington AM; Tansey P; Tait RC
Br J Haematol; 2012 Jul; 158(2):256-261. PubMed ID: 22571356
[TBL] [Abstract][Full Text] [Related]
32. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.
Tang HL; Shi WL; Li XG; Zhang T; Zhai SD; Xie HG
Pharmacogenomics J; 2015 Dec; 15(6):496-504. PubMed ID: 25869011
[TBL] [Abstract][Full Text] [Related]
33. Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.
Cerezo-Manchado JJ; Roldán V; Corral J; Rosafalco M; Antón AI; Padilla J; Vicente V; González-Conejero R
Thromb Haemost; 2016 Jan; 115(1):117-25. PubMed ID: 26538428
[TBL] [Abstract][Full Text] [Related]
34. Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study.
Lee KE; Yee J; Lee GY; Chung JE; Seong JM; Chang BC; Gwak HS
Sci Rep; 2020 Apr; 10(1):6988. PubMed ID: 32332930
[TBL] [Abstract][Full Text] [Related]
35. Genetic influence on bleeding and over-anticoagulation risk in patients undergoing warfarin treatment after heart valve replacements.
Zhou L; Ding Y; Gao Y; Yang B; Bao J; Ma J
Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):1-9. PubMed ID: 31914334
[No Abstract] [Full Text] [Related]
36. Clinical Application of Genotype-guided Dosing of Warfarin in Patients with Acute Stroke.
Šupe S; Poljaković Z; Božina T; Ljevak J; Macolić Šarinić V; Božina N
Arch Med Res; 2015 May; 46(4):265-73. PubMed ID: 25989350
[TBL] [Abstract][Full Text] [Related]
37. Influence of UDP-Glucuronosyltransferase Polymorphisms on Stable Warfarin Doses in Patients with Mechanical Cardiac Valves.
An SH; Chang BC; Lee KE; Gwak HS
Cardiovasc Ther; 2015 Dec; 33(6):324-8. PubMed ID: 26223945
[TBL] [Abstract][Full Text] [Related]
38. Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects.
Kadian-Dodov DL; van der Zee SA; Scott SA; Peter I; Martis S; Doheny DO; Rothlauf EB; Lubitz SA; Desnick RJ; Halperin JL
Vasc Med; 2013 Oct; 18(5):290-7. PubMed ID: 24029542
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.
Zambon CF; Pengo V; Moz S; Bozzato D; Fogar P; Padoan A; Plebani M; Groppa F; De Rosa G; Padrini R
Eur J Clin Pharmacol; 2018 May; 74(5):571-582. PubMed ID: 29396738
[TBL] [Abstract][Full Text] [Related]
40. [Influence of warfarin related genes and non- genetic factors on administrative dose in Shanghai area].
Zhuang W; Wu D; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):13-7. PubMed ID: 24602724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
